Project Grant H79TI087778

Award Date 9/30/24
Completion Date 9/29/27
Dollars Obligated $1.5M
Federal Grant Program
93.243
Assistance Type
Project Grant
Place of Performance
U.S. Virgin Islands
Similar Awards
The Virgin Islands Department of Health Group received a $608,850 Block Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Block Grants for Prevention and Treatment of Substance Abuse (CFDA 93.959) program. This two-year grant, awarded on October 1, 2024, will support the organization's comprehensive substance abuse prevention, treatment, and rehabilitation activities in the U.S. Virgin Islands. The funding will enable the Virgin Islands...
The Virgin Islands Department of Health Group received a $375,000 block grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) to deliver community mental health services under the Block Grants for Community Mental Health Services program (CFDA 93.958). The four-year award, issued on September 1, 2021 and running through September 30, 2025, will support the Virgin Islands' plan to provide comprehensive services to adults with serious mental illness and children...
This federal Block Grant award of $560,493 from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Block Grants for Community Mental Health Services program (CFDA 93.958) provides funding to the Virgin Islands Department of Health Group to deliver comprehensive community mental health services to adults with serious mental illness and children with serious emotional disturbance across the U.S. Virgin Islands. The award period is from October 1, 2024, to September...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $37,611,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the Puerto Rico Mental Health and Anti-Addiction Services Administration (MHAASA). The 3-year grant aims to implement a comprehensive strategy addressing opioid use through evidence-based prevention, harm reduction, treatment, and recovery initiatives in Puerto...
The U.S. Department of Health and Human Services, through the Substance Abuse and Mental Health Services Administration (SAMHSA), awarded a $2,000,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the American Samoa Department of Health (DOH) Behavioral Health Services Division. The grant, with an award date of September 30, 2024 and an ultimate completion date of September 29, 2027, will fund several...
The Virgin Islands Department of Health Group was awarded a $109,846 Formula Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Projects for Assistance in Transition from Homelessness (PATH) program (CFDA 93.150). The grant period runs from September 1, 2024 to August 31, 2026. The PATH program provides formula grants to state and territorial agencies to support comprehensive services for individuals experiencing serious mental illness, co-occurring...
The U.S. Virgin Islands Department of Health Group has been awarded a $2,012,590 Cooperative Agreement under the HIV Prevention Activities Non-Governmental Organization Based Federal Grant Program (CFDA 93.939) by the National Center for HIV/AIDS, a civilian agency of the U.S. Department of Health and Human Services. The purpose of this 5-year award, effective August 1, 2024, is to implement a comprehensive multi-sectoral approach to combat the HIV epidemic in the U.S. Virgin Islands. Key...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $1,656,459 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the City of Providence, Rhode Island. The grant, titled "The Providence Overdose Prevention Project," aims to increase the capacity of Providence Emergency Medical Services to implement evidence-based practices that engage people who use drugs and connect...
The U.S. Virgin Islands Department of Health Group received a $460,490 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) grant program. The award period runs from August 1, 2024 through July 31, 2029. The funding will support the USVI Behavioral Risk Factor Surveillance System, which aims to collect, analyze, and disseminate data on health-related behaviors,...
This federal Project Grant award, with a total obligated amount of $5,537,774.00, was provided by the Maternal and Child Health Bureau, a part of the Health Resources and Services Administration (HRSA), under the Maternal and Child Health Federal Consolidated Programs (CFDA 93.110). The award supports the "AMERICAN RESCUE PLAN ACT - PEDIATRIC MENTAL HEALTH CARE ACCESS NEW AREA EXPANSION" initiative, which aims to expand access to pediatric mental health care services in the U.S. Virgin...

The U.S. Virgin Islands Department of Health Group received a $1,500,000 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant funding will be used to implement a comprehensive naloxone distribution and saturation plan across the U.S. Virgin Islands. This initiative aims to address critical gaps identified in the territory's opioid overdose needs assessment by expanding access to treatment, reducing barriers to care, and enhancing harm reduction services. The project will focus on high-risk populations and underserved communities to significantly reduce overdose mortality and improve public health outcomes in the U.S. Virgin Islands. The award period runs from September 30, 2024 to September 29, 2027.

Generated 7/8/25, 12:57 PM